The Sacklers Consider Adding Another $1 Billion to the Purdue Settlement Posted on February 11, 2022 by The National Trial Lawyers Members of the billionaire Sackler family that owns Purdue Pharma are weighing whether to add $1 billion to the OxyContin-maker’s faltering opioid settlement bid in an effort to win over holdouts, Bloomberg News reported on Thursday. The addition would bring the family’s total contribution to $5.325 billion to get a handful of U.S. state attorneys general to drop their opposition to Purdue’s bankruptcy plan, the report said citing people familiar with the matter. Purdue did not immediately respond to a request for comment. Read the source article at Yahoo Finance
